Zanubrutinib 80mg capsules
NHS hospitals in England used £149,209,150 of indicative cost of Zanubrutinib 80mg capsules in the 12 months to July 2026, about 0.6% of all hospital medicines spend. That is up 66.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Zanubrutinib 80mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Zanubrutinib 80mg capsules most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Western Sussex Hospitals Nhs Found Trust | £4,059,318 |
| Univ Hpl B/Ham Nhs Foundation Trust | £3,627,158 |
| The Christie Nhs Foundation Trust | £3,513,758 |
| Hull And East Yorkshire Hpls Nhs Trust | £3,380,931 |
| University College London Foundation Tr | £3,269,114 |
| East Sussex Healthcare Nhs Trust | £3,017,977 |
| University Hpls Of Leicester Nhs Trust | £2,971,647 |
| University Hospitals Dorset Nhs Ft | £2,761,769 |
| South Tyneside And Sunderland Nhs Ft | £2,641,222 |
| Norfolk & Norwich University Hpl Nhs Trt | £2,562,898 |
The primary-care picture
Zanubrutinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Zanubrutinib medicine page.